Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 19% ± 2% | |
epithelial cell | 3 studies | 26% ± 6% | |
oligodendrocyte | 3 studies | 20% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3919.26 | 1445 / 1445 | 100% | 50.84 | 183 / 183 |
skin | 100% | 4559.22 | 1809 / 1809 | 100% | 36.23 | 472 / 472 |
stomach | 100% | 3060.79 | 359 / 359 | 100% | 37.28 | 286 / 286 |
prostate | 100% | 4846.37 | 245 / 245 | 100% | 29.54 | 501 / 502 |
ovary | 100% | 4991.29 | 180 / 180 | 100% | 43.42 | 429 / 430 |
intestine | 100% | 3945.27 | 966 / 966 | 100% | 36.02 | 525 / 527 |
bladder | 100% | 3970.52 | 21 / 21 | 100% | 33.13 | 502 / 504 |
lung | 100% | 3444.88 | 578 / 578 | 100% | 35.54 | 1150 / 1155 |
breast | 100% | 4118.16 | 459 / 459 | 99% | 39.51 | 1112 / 1118 |
pancreas | 100% | 2306.26 | 328 / 328 | 99% | 26.50 | 177 / 178 |
uterus | 100% | 5639.21 | 170 / 170 | 99% | 40.31 | 456 / 459 |
thymus | 100% | 6203.04 | 653 / 653 | 99% | 28.16 | 600 / 605 |
brain | 99% | 3024.81 | 2618 / 2642 | 100% | 25.29 | 703 / 705 |
adrenal gland | 100% | 3540.72 | 258 / 258 | 99% | 29.89 | 227 / 230 |
kidney | 100% | 3280.44 | 89 / 89 | 97% | 20.83 | 873 / 901 |
liver | 100% | 2320.63 | 226 / 226 | 93% | 16.84 | 376 / 406 |
adipose | 100% | 3472.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 24.96 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.74 | 29 / 29 |
spleen | 100% | 3897.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.85 | 1 / 1 |
blood vessel | 100% | 3972.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2256.48 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2453.89 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 2101.79 | 742 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007029 | Biological process | endoplasmic reticulum organization |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0006685 | Biological process | sphingomyelin catabolic process |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000139 | Cellular component | Golgi membrane |
GO_0042383 | Cellular component | sarcolemma |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005640 | Cellular component | nuclear outer membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0050290 | Molecular function | sphingomyelin phosphodiesterase D activity |
GO_0004767 | Molecular function | sphingomyelin phosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | SMPD4 |
Protein name | Sphingomyelin phosphodiesterase 4 Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III) Alternative protein SMPD4 |
Synonyms | KIAA1418 SKNY |
Description | FUNCTION: Catalyzes the hydrolysis of membrane sphingomyelin to form phosphorylcholine and ceramide . It has a relevant role in the homeostasis of membrane sphingolipids, thereby influencing membrane integrity, and endoplasmic reticulum organization and function . May sensitize cells to DNA damage-induced apoptosis . In skeletal muscle, mediates TNF-stimulated oxidant production (By similarity). . |
Accessions | ENST00000449159.5 ENST00000433118.5 ENST00000351288.10 [Q9NXE4-2] ENST00000680810.1 ENST00000435455.6 ENST00000412570.5 A0A7P0Z453 A0A7P0TB44 F2Z2W5 F2Z2I0 H7C235 ENST00000451542.5 H7C1Q6 H7C2E2 ENST00000441135.1 ENST00000431183.6 [Q9NXE4-6] H7C2J2 A0A7P0TB24 L8ECH3 ENST00000680987.1 ENST00000680196.1 F8WF03 A0A7P0T8J0 A0A7P0T9J6 ENST00000454468.5 ENST00000680679.1 A0A7P0TAZ0 H7C0W5 ENST00000709800.1 [Q9NXE4-6] ENST00000439886.5 ENST00000709804.1 [Q9NXE4-2] ENST00000709809.1 [Q9NXE4-1] C9J647 ENST00000439029.5 ENST00000457039.6 F8WEQ5 ENST00000430682.5 ENST00000680401.1 Q9NXE4 ENST00000680298.1 ENST00000409031.5 [Q9NXE4-1] |